No Data
Express News | Beigene Announces Appointment of Giancarlo Benelli as Head of Europe
BeiGene Announces Appointment of Giancarlo Benelli as Head of Europe
Nona Biosciences Announces Update on Its Collaborator DualityBio's Antibody-Drug Conjugate (ADC) Collaboration With BeiGene
News On BeiGene Ltd. (BGNE) Now Under ONC
BEIGENE has issued approximately 0.2565 million shares due to the return of restricted stock units.
BEIGENE (06160) announced that on December 31, 2024, approximately 0.2231 million shares will be issued due to the vesting of restricted stock units granted under the equity plan (excluding company Directors), and approximately 0.0334 million shares will be issued due to the vesting of restricted stock units granted to company Directors under the equity plan. A total of approximately 0.394 million shares will be issued from exercising stock options between December 1, 2024, and December 31, 2024.
Duality Biologics Announces B7H4 ADC Milestone Achievement and License Exercise by BeiGene
